• 10-01-2019

    We would like to draw your attention to an exciting podcast on the subject of tuberculosis.  The podcast presents a research project of the Hasso Plattner Institute on how Artificial Intelligence can help diagnose tuberculosis in South Africa. Click here for the […]

  • 08-28-2019

    On 14 August 2019, a drug combination for the treatment of XDR tuberculosis and MDR tuberculosis was approved by the US Food and Drug Administration (FDA). This combination contains the new tuberculosis drug pretomanid as a combination partner with linezolid and bedaquiline […]

  • 08-13-2019

    Last week, there was an article in the daily press about a Tuberculosis outbreak at a school in Baden-Württemberg in which 4 children contracted tuberculosis (TB) and more than 100 children were infected. Should we now be worried that TB will return […]

  • 07-16-2019

    On July 12, 2019, the German Central Committee against Tuberculosis (DZK) (Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose; DZK e.V.) held a meeting with a high-ranking delegation of Chinese health authorities on the premises of the Emil von Behring HELIOS Clinic.   The […]


Combating tuberculosis – we are your contact!

Welcome to DZK online

The German Central Committee against Tuberculosis (DZK) was founded on 21 November 1895 in Berlin, at a time when tuberculosis was a widespread disease and one in four persons died of tuberculosis.

The importance of tuberculosis was so great at the time that the Reich Chancellor assumed the honorary presidency and the Minister of the Interior the presidency.

Thanks to the high level of expertise of the domestic and foreign staff in the individual working groups, the DZK, which is closely linked to the German Society for Pneumology and Respiratory Medicine, is still an important decision-maker in all questions of tuberculosis control today; the government agencies at the federal and state levels rely on its work. The activities of the DZK are also of great importance because, compared with other industrial countries, there are only few institutions for research, teaching, and patient care in the area of lung diseases in Germany.